section name header

Y-Site Injection Compatibility (1:1 Mixture)

Idarubicin HCl

(Mfr: AD)(Conc: 0.5 mg/mLa)

I

Piperacillin sodium-tazobactam sodium

(Mfr: LEf)(Conc: 40 mg/mLa,h)

Remarks:

Immediate increase in haze

Ref:

1688